|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,575.12 |
3.39% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,906.05 |
2.97% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$59,469.20 |
2.86% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$52,176.06 |
2.51% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$51,324.93 |
2.46% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,864.30 |
2.30% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$47,724.81 |
2.29% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$46,192.70 |
2.22% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,918.68 |
2.20% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,754.80 |
2.20% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,325.30 |
2.18% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$45,397.95 |
2.18% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$44,944.28 |
2.16% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,063.09 |
2.12% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,567.28 |
2.09% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$43,012.20 |
2.07% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,821.64 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$42,672.17 |
2.05% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,728.86 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,615.04 |
2.05% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$42,424.69 |
2.04% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,580.67 |
2.04% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$41,985.87 |
2.02% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,662.50 |
2.00% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$41,255.08 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,401.00 |
1.94% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$39,929.61 |
1.92% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$39,483.41 |
1.90% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$39,424.64 |
1.89% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$39,270.92 |
1.89% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$39,208.50 |
1.88% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,053.61 |
1.88% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$38,869.11 |
1.87% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,330.84 |
1.84% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,405.40 |
1.84% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$37,837.36 |
1.82% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,952.37 |
1.82% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$37,840.40 |
1.82% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,852.11 |
1.82% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$36,212.28 |
1.74% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,773.82 |
1.72% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$35,624.97 |
1.71% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,682.35 |
1.62% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$33,612.02 |
1.61% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$33,359.83 |
1.60% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$32,583.44 |
1.56% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$31,880.86 |
1.53% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,012.75 |
1.49% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$30,725.11 |
1.48% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$26,298.61 |
1.26% |
| US Dollar |
$USD |
|
1,471 |
$1,470.64 |
0.07% |
| Euro |
$EUR |
|
537 |
$634.21 |
0.03% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|